Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,060,000 | 8,180,000 | 7,197,000 | 6,597,000 | 5,668,000 |
| Depreciation Amortization | 2,093,000 | 2,124,000 | 1,869,000 | 1,662,000 | 1,605,000 |
| Income taxes - deferred | -235,000 | -676,000 | -720,000 | -74,000 | -106,000 |
| Accounts receivable | -599,000 | -108,000 | -685,000 | -516,000 | -159,000 |
| Other Working Capital | -1,021,000 | 936,000 | 1,331,000 | -198,000 | 1,592,000 |
| Other Operating Activity | 1,501,000 | 633,000 | 1,603,000 | 705,000 | 264,000 |
| Operating Cash Flow | $11,799,000 | $11,089,000 | $10,595,000 | $8,176,000 | $8,864,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,478,000 | -1,938,000 | -1,927,000 | -1,943,000 | -1,568,000 |
| Net Acquisitions | -987,000 | -580,000 | -2,812,000 | -478,000 | -225,000 |
| Purchase Of Investment | -5,660,000 | -11,617,000 | -7,590,000 | -6,923,000 | -8,188,000 |
| Sale Of Investment | 9,187,000 | 12,061,000 | 8,062,000 | 7,353,000 | 5,967,000 |
| Other Investing Activity | -341,000 | -273,000 | -259,000 | -206,000 | -79,000 |
| Investing Cash Flow | $-279,000 | $-2,347,000 | $-4,526,000 | $-2,197,000 | $-4,093,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,215,000 | 514,000 | 3,062,000 | 2,359,000 | 338,000 |
| Debt Issued | 6,000 | 17,000 | 1,023,000 | 22,000 | 14,000 |
| Debt Repayment | -196,000 | -395,000 | -196,000 | -245,000 | -391,000 |
| Common Stock Issued | 774,000 | 684,000 | 311,000 | 390,000 | 514,000 |
| Common Stock Repurchased | -1,717,000 | -1,384,000 | -1,183,000 | -6,538,000 | -2,570,000 |
| Dividend Paid | -3,793,000 | -3,251,000 | -2,746,000 | -2,381,000 | -2,047,000 |
| Other Financing Activity | -732,000 | -1,291,000 | -4,134,000 | -560,000 | -1,109,000 |
| Financing Cash Flow | $-4,443,000 | $-5,106,000 | $-3,863,000 | $-6,953,000 | $-5,251,000 |
| Exchange Rate Effect | -225,000 | 190,000 | 277,000 | 110,000 | -40,000 |
| Beginning Cash Position | 9,203,000 | 5,377,000 | 2,894,000 | 3,758,000 | 4,278,000 |
| End Cash Position | 16,055,000 | 9,203,000 | 5,377,000 | 2,894,000 | 3,758,000 |
| Net Cash Flow | $6,852,000 | $3,826,000 | $2,483,000 | $-864,000 | $-520,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,799,000 | 11,089,000 | 10,595,000 | 8,176,000 | 8,864,000 |
| Capital Expenditure | -2,632,000 | -2,175,000 | -2,262,000 | -2,099,000 | -1,731,000 |
| Free Cash Flow | 9,167,000 | 8,914,000 | 8,333,000 | 6,077,000 | 7,133,000 |